[1]史春燕,黄 燕,杨 爽,等.穴位贴敷治疗慢阻肺的效果评价方法[J].医学信息,2022,35(21):174-176.[doi:10.3969/j.issn.1006-1959.2022.21.047]
　SHI Chun-yan,HUANG Yan,YANG Shuang,et al.Effect Evaluation Method of Acupoint Application in Treating Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(21):174-176.[doi:10.3969/j.issn.1006-1959.2022.21.047]
点击复制

穴位贴敷治疗慢阻肺的效果评价方法()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年21期
页码:
174-176
栏目:
综述
出版日期:
2022-11-01

文章信息/Info

Title:
Effect Evaluation Method of Acupoint Application in Treating Chronic Obstructive Pulmonary Disease
文章编号:
1006-1959（2022）21-0174-04
作者:
史春燕; 黄 燕; 杨 爽; 等
（1.内蒙古医科大学研究生院，内蒙古 呼和浩特 010050；2.内蒙古自治区中医医院肺病科，内蒙古 呼和浩特 010010）
Author(s):
SHI Chun-yan; HUANG Yan; YANG Shuang; et al.
(1.Graduate School of Inner Mongolia Medical University,Hohhot 010050,Inner Mongolia,China;2.Department of Pulmonary Diseases,Traditional Chinese Medicine Hospital of Inner Mongolia Autonomous Region,Hohhot 010010,Inner Mongolia,China)
关键词:
慢性阻塞性肺疾病; 中医肺康复; 穴位贴敷; 评价方法
Keywords:
Chronic obstructive pulmonary disease; Lung rehabilitation of traditional Chinese medicine; Acupoint application; Evaluation method
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2022.21.047
文献标志码:
A
摘要:
慢性阻塞性肺疾病分为发作期和稳定期，在稳定期控制该病的急性发作是治疗的关键。穴位贴敷治疗是用于慢阻肺稳定期的常见中医肺康复方法，临床疗效显著，但目前缺乏系统、统一的评价穴位贴敷治疗效果的方法。本文对常用的评价穴位贴敷疗法的指标进行综述，以期为穴位贴敷的临床应用提供一定参考依据。
Abstract:
Chronic obstructive pulmonary disease is divided into attack period and stable period. Controlling the acute attack of the disease in the stable period is the key to treatment. Acupoint application therapy is a common pulmonary rehabilitation method of traditional Chinese medicine for stable chronic obstructive pulmonary disease, and the clinical effect is remarkable. However, there is no systematic and unified method to evaluate the effect of acupoint application therapy. This article reviews the commonly used evaluation indicators of acupoint application therapy, in order to provide a reference for the clinical application of acupoint application.

参考文献/References:

[1]Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J].Lancet,2018,391(10131):1706-1717.[2]鄢凤菊.中西医框架下冬病夏治理论结合穴位贴敷治疗慢阻肺的探讨[J].中西医结合心血管病电子杂志,2015,3(1):53,55.[3]姜美伊,冯晓纯.浅谈穴位贴敷的作用机理及其在儿科临床的应用[C]//中华中医药学会第34次全国中医儿科学术大会暨2017年广东省中西医结合儿科学术交流会.2017:950-953.[4]赵洪霄,李英,杨爱萍,等.穴位贴敷联合百合固金汤加减治疗慢性支气管炎肺肾阴虚证的疗效和机制研究[J].吉林中医药,2020,40(6):830-833. [5]秦岚.穴位敷贴辅助治疗轻、中度COPD中老年患者的效果及对肺功能的影响[J].现代诊断与治疗,2019,30(13):2174-2175.[6]吕明圣.清热化痰通腑穴位贴敷辅助治疗AECOPD痰热壅肺证疗效观察[D]北京:北京中医药大学,2019.[7]曾丽珍.“冬夏并治”穴位贴敷治疗慢性阻塞性肺疾病的回顾性研究[D].南昌:江西中医药大学,2019.[8]窦钊,孙增涛.不同表型慢阻肺患者在“冬病夏治”穴位贴敷法中的疗效差异[J].辽宁中医杂志,2015,42(3):581-582.[9]张云伟,周燕,廖小琴,等.穴位贴敷治疗慢性阻塞性肺疾病稳定期疗效观察[J].上海针灸杂志,2016,35(9):1065-1069.[10]常力,刘桂颖,尹新中,等.敷贴疗法对慢性阻塞性肺疾病稳定期干预的临床研究[J].中华中医药杂志,2016,31(12):5143-5145.[11]臧敏,陈秀华,林文波,等.中医外治法治疗慢性阻塞性肺疾病稳定期疗效及对免疫功能的影响[J].浙江中西医结合杂志，2016,26(11):1006-1008.[12]苏娅.“冬病夏治”麝香消喘膏穴位贴敷治疗慢性阻塞性肺疾病稳定期的临床疗效及机制研究[D].呼和浩特:内蒙古医科大学,2020.[13]王敬民.穴位贴敷治疗慢性阻塞性肺疾病稳定期临床研究[J].内蒙古中医药,2020,39(6):118-120.[14]张加权,周明娅,王珍秀.冬病夏治中药穴位贴敷防治慢性阻塞性肺疾病稳定期56例临床观察[J].湖南中医杂志,2020,36(3):4-6.[15]周胜利,李京,童佳兵,等.中药穴位贴敷对COPD稳定期肺肾气虚证肺功能及生活质量影响[J].辽宁中医药大学学报,2016,18(12):84-87.[16]冯林焰,陈志斌,黄玉兰,等.培土生金穴位贴敷疗法在COPD稳定期肺脾气虚证患者肺康复中的应用[J].中医药临床杂志,2016,28(7):966-969.[17]卢军仪,赵丹,孙义田,等.穴位贴敷组方治疗痰热郁肺型急性加重期慢性阻塞性肺疾病的临床观察[J].世界中西医结合杂志,2021,16(7):1324-1328. [18]孙红红,武自力,何永杰,等.咳喘敷贴治疗慢性阻塞性肺疾病急性发作期疗效分析[J].中国中西医结合急救杂志,2020,27(3):287-290.[29]王烨林,丁以艳,孙思庆.穴位贴敷联合常规西药治疗慢性阻塞性肺疾病稳定期患者[J].世界中医药,2020,15(3):463-467.[20]孟兆平.中药穴位敷贴治疗慢性阻塞性肺疾病效果研究[J].白求恩医学杂志,2016,14(4):481-482.[21]周胜利,李京,童佳兵,等.中药穴位贴敷治疗慢性阻塞性肺疾病稳定期肺肾气虚证[J].吉林中医药,2016,36(12):1282-1285.[22]董敏,王兰娣.穴位贴敷治疗慢性阻塞性肺疾病稳定期临床观察[J].西部中医药,2017,30(3):115-118.[23]李竹英,孙丽丽,李寒梅.平喘颗粒对哮喘慢性持续期患者免疫功能的影响[J].中医药学报,2021,49(3):72-75.[24]拓国峰,冯文奎,沈海虎.血清炎症因子及血浆渗透压与慢阻肺的关系[J].贵州医药,2019,43(7):1078-1079.[25]周昌妮,韩德恩,徐如冰,等.舒肺贴对COPD大鼠肺组织IL-8、TNF-α及黏蛋白MUC5AC表达的影响[J].中成药,2016,38(11):2319-2324.[26]王健,程建军.中药穴位贴敷联合布地奈德雾化吸入治疗慢性阻塞性肺疾病的疗效及对患者生活质量的影响[J].中国医师杂志,2019,21(2):277-279.[27]屈磊,周良琼,龚传明,等.中药穴位贴敷对AECOPD的疗效及对血清炎性因子水平的影响[J].西南国防医药,2016,26(9):1070-1072.

相似文献/References:

[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
　ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
　CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
　WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(21):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
　LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及 炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
　LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(21):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病 引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
　ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并 重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
　JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Journal of Medical Information,2018,31(21):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]何冬兰,李 文.NLR、PLR在慢性阻塞性肺疾病进展、预后中的相关研究[J].医学信息,2022,35(11):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
　HE Dong-lan,LI Wen.Study on Correlation Between NLR and PLR in the Progression and Prognosis of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(21):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
[10]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及 MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
　ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]

更新日期/Last Update: 1900-01-01